Skip to main content
Journal cover image

Sudden cardiac death after acute heart failure hospital admission: insights from ASCEND-HF.

Publication ,  Conference
Pokorney, SD; Al-Khatib, SM; Sun, J-L; Schulte, P; O'Connor, CM; Teerlink, JR; Armstrong, PW; Ezekowitz, JA; Starling, RC; Voors, AA; Mentz, RJ ...
Published in: Eur J Heart Fail
March 2018

AIMS: The incidence of and factors associated with sudden cardiac death (SCD) early after an acute heart failure (HF) hospital admission have not been well defined. METHODS AND RESULTS: We assessed SCD and ventricular arrhythmias in the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure (ASCEND-HF) trial, which included patients with acute HF with reduced or preserved ejection fraction. SCD, resuscitated SCD (RSCD), and sustained ventricular tachycardia/ventricular fibrillation (VT/VF) were adjudicated from randomization through 30 days and were combined into a composite endpoint. Baseline characteristics associated with this composite were determined by logistic regression. RSCD and VT/VF were included as time-dependent variables in a Cox model evaluating the association of these variables with 180-day all-cause mortality. Among 7011 patients, the 30-day all-cause mortality rate was 3.8%; SCD accounted for 17% of these deaths. The 30-day composite event rate was 1.8% (n = 121). Ten patients had more than one event with 30-day Kaplan-Meier event rates of 0.6% for SCD [95% confidence interval (CI) 0.5%-0.9%, n = 43], 0.4% for RSCD (95% CI 0.2%-0.5%, n = 24), and 0.9% for VT/VF (95% CI 0.7%-1.2%, n = 64). In the multivariable model, chronic obstructive pulmonary disease, history of VT, male sex, and longer QRS duration were associated with SCD, RSCD, or VT/VF. A RSCD or VT/VF event was associated with higher 180-day mortality (adjusted hazard ratio 6.6, 95% CI 4.8-9.1, P < 0.0001). CONCLUSIONS: Approximately 2% of patients admitted for acute HF experienced SCD, RSCD, or VT/VF within 30 days of admission, and SCD accounted for 17% of all deaths within 30 days.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Eur J Heart Fail

DOI

EISSN

1879-0844

Publication Date

March 2018

Volume

20

Issue

3

Start / End Page

525 / 532

Location

England

Related Subject Headings

  • United States
  • Treatment Outcome
  • Survival Rate
  • Stroke Volume
  • Risk Factors
  • Risk Assessment
  • Patient Admission
  • Natriuretic Peptide, Brain
  • Natriuretic Agents
  • Middle Aged
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Pokorney, S. D., Al-Khatib, S. M., Sun, J.-L., Schulte, P., O’Connor, C. M., Teerlink, J. R., … Mentz, R. J. (2018). Sudden cardiac death after acute heart failure hospital admission: insights from ASCEND-HF. In Eur J Heart Fail (Vol. 20, pp. 525–532). England. https://doi.org/10.1002/ejhf.1078
Pokorney, Sean D., Sana M. Al-Khatib, Jie-Lena Sun, Phillip Schulte, Christopher M. O’Connor, John R. Teerlink, Paul W. Armstrong, et al. “Sudden cardiac death after acute heart failure hospital admission: insights from ASCEND-HF.” In Eur J Heart Fail, 20:525–32, 2018. https://doi.org/10.1002/ejhf.1078.
Pokorney SD, Al-Khatib SM, Sun J-L, Schulte P, O’Connor CM, Teerlink JR, et al. Sudden cardiac death after acute heart failure hospital admission: insights from ASCEND-HF. In: Eur J Heart Fail. 2018. p. 525–32.
Pokorney, Sean D., et al. “Sudden cardiac death after acute heart failure hospital admission: insights from ASCEND-HF.Eur J Heart Fail, vol. 20, no. 3, 2018, pp. 525–32. Pubmed, doi:10.1002/ejhf.1078.
Pokorney SD, Al-Khatib SM, Sun J-L, Schulte P, O’Connor CM, Teerlink JR, Armstrong PW, Ezekowitz JA, Starling RC, Voors AA, Velazquez EJ, Hernandez AF, Mentz RJ. Sudden cardiac death after acute heart failure hospital admission: insights from ASCEND-HF. Eur J Heart Fail. 2018. p. 525–532.
Journal cover image

Published In

Eur J Heart Fail

DOI

EISSN

1879-0844

Publication Date

March 2018

Volume

20

Issue

3

Start / End Page

525 / 532

Location

England

Related Subject Headings

  • United States
  • Treatment Outcome
  • Survival Rate
  • Stroke Volume
  • Risk Factors
  • Risk Assessment
  • Patient Admission
  • Natriuretic Peptide, Brain
  • Natriuretic Agents
  • Middle Aged